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Mass spectrometry has been actively involved in the areas of healthcare, 
pharmaceutics, environmental analysis, food industry and forensics due to its ability to 
provide molecular information at trace levels. Recently, because of the complexity of 
chemical and biological samples, computer-assisted mass spectra analysis, including signal 
enhancement, statistics and machine learning, has been drawn more and more attention 
especially for researches in biomarker identification, sample classification and omics-
related areas where high volume of data is generated.  
Typically, mass spectra analysis follows two steps. Firstly, signal enhancement is 
performed to systematically filter out the background noise and enhance the detected 
signals. Secondly, data mining is used to extract the meaningful signals in the mass spectra. 
Depending on the mechanisms of mass spectrometry and nature of samples, different 
methods in signal enhancement and data mining are developed to address the needs.   
Image current measurement followed by Fourier transform is a non-destructive mass 
analysis method and has been widely used for Fourier transform ion cyclotron resonance, 
Orbitrap mass spectrometers and recently quadrupole ion traps. The phase between the ion 
excitation and the image current measurement typically needs to be well controlled 
xiv 
 
for obtaining high quality spectra.  In this thesis, a data processing method based on self-
correlation (SC) function has been explored for signal enhancement with image current 
data recorded at random phases.  The simple algorithm of the SC method was introduced 
and a series of data used for demonstrations was simulated based on a previous study on 
non-destructive mass analysis using an ion trap.  A significant improvement has been 
achieved in the signal-to-noise ratio (SNR) as well as in the accuracy of the peak ratio. 
The efficiency of using a mask data set for selected ion monitoring has also been 
demonstrated. 
In recent researches in chemical and biological studies, biomarker profiling using 
mass spectrometry plays an essential role in biological studies and is high dependent on 
the data analysis for sample classification. In this thesis, power normalization of the mass 
spectra has been proposed as a method of altering the weights of peaks at different intensity 
levels.  In combination of the supporting vector machine method, its impact on the sample 
classification has been characterized using the data in four studies previously reported for 
distinguishing anomeric configurations of sugars, types of bacteria, stages of melanoma 
and types of breast cancer.  Comprehensive analysis of the data with normalization at 
different power normalization index (PNI) was developed with analysis tools, including 
error-PNI plots, reference profiles and error source profiles, to assess the analytical method 




CHAPTER 1.! INTRODUCTION 
Mass spectrometry has been actively involved in the areas of healthcare,1-3 
pharmaceutics,4-6 environmental analysis,7,8 food industry9-11 and forensics12,13 due to its 
ability to provide molecular information at trace levels. With the booming of electronics 
and computers as well as simplified operations in sample preparation, huge quantities of 
mass spectra with highly detailed information have been constantly generated in recent 
decades, especially in the health care and omics-related fields.14,15 Accordingly, computer-
assisted analysis has been developed to help scientists in understanding the mass spectra 
instead of the visual-based interpretation.16-18 As a result, the informatics and data science 
in mass spectrometry, including data processing, statistics, algorithm design and machine 
learning, have drawn more and more attention. 
 
1.1! Mass spectra collection and mass spectrometry 
Mass spectrometry consists of an ion source, a mass analyzer and a detector (Figure 
1.1). Sequentially, molecules in a sample are first ionized by ion sources such as electron 
ionization (EI),19,20 electrospray ionization (ESI),21,22 low temperature plasma desorption 
(LTP),23 matrix-assisted laser desorption ionization (MALDI)24 and paper spray ionization 




     Equation 1.1 
where M is the molecule in a sample and H is a proton. 
 
Figure 1.1 Work flow of sample analysis using mass spectrometry. 
Then, generated ions are transferred and separated into mass analyzers based on mass-
over-charge ratio (m/z). In detail, different mass analyzers have different mechanisms to 
analyze ions. For example, quadrupole and ion trap analyzers separate ions mostly by 
boundary ejection based on the stability diagram, while Fourier transform mass 
spectrometry detects ions based on the difference of characteristic secular frequencies; 
additionally the Time-of-flight mass analyzer distinguishes ions based on the drifting 
velocity of accelerating ions with different charge and mass. During researches requiring 
mass spectrometry, those mass analyzers are chosen based on the experimental conditions 
and sample properties.  
At last, desired ions are recorded in the detector and displayed by computer. The result 
appears as a spectrum with the X axis representing m/z ratio and the Y axis representing 
relative intensity. As an example, mass spectra of C20H42 and C100H202 have been shown in 
 
M + e− → M i+ + 2e−





























Figure 2.2, where the monoisotopic mass is 282 and 1403 for alkanes with 20 and 100 
carbon atoms, respectively.27 Constitutional isomers, which are molecules with the same 
m/z ratios, can further be identified by tandem MS. During this process, energy applied to 
the molecule induces bond cleavage and generates charged fragments, which are unique 
for different structures due to bond energy difference. 
 
Figure 1.2 Theoretical mass spectrum with isotopic distribution of (a) C20H42 and (b) 
C100H202. 
 
Mass spectra contain the information both of the type of molecules in a sample, which 
is shown as peaks on specific m/z positions, and the relative concentration of that molecule 
compared to the others, which is shown as intensity of the peaks. In order to quantify the 
concentration precisely, an internal standard, which is usually the isotope-labeled molecule 
or other similarly structured molecules with known concentration, is added to the sample. 
Then, the intensity ratio of the detected molecule and internal standard are analyzed to 
determine the precise concentration in the drug. This precision is important in situations 
such as the analysis of abusive drug metabolites remains in blood.28 
Peaks intensities are affected tremendously by experimental parameters. For example, 




in different dominant peaks due to the efficiency and stability of ionization, desolvation, 
fragmentation and so on (Figure 1.3).  Thus, those parameters have to be carefully tuned 
to obtain the desired mass spectra. Even with the same parameters, the instrument 
conditions such as electronic interference, environment conditions such as moisture level 
vacuum levels, and labor difference may also introduce variance into the mass spectra.  
 
Figure 1.3 Isolation of two peaks m/z 221 and m/z 223 from 18O-labeled β-D-Glcp-(1-3)-
D-Glc at collision energy (a) 5V (b) 10V and (c) 15Vin Ion trap mass spectrometry.29 
 
Another source of interference is the matrix effect, which is the combined effect of 
molecular components of a sample other than the analyte of interest. The matrix effect 
gives rise to a large number of peaks in mass spectra.  Unlike the variance from the 
instrument conditions discussed above, matrix effects are truly existing molecules in the 
mass spectrometry, which cannot be averaged to be eliminated. For example, in the 
analysis of lipid profiles of the bacteria cell membrane, the molecules from growth media 
constantly cover the mass range of m/z 50 to 250. Another frequently used sample, blood, 
also has a variety of molecules, which usually have dominant intensity compared to the 
desired analyte in the mass spectra.28,30 Thus, finding characteristic peaks of the analyte 




required, especially when using the high-resolution mass spectrometry, where high 
volumes of data are collected.  
 
Figure 1.4 Mass spectra of bacteria (a)SAR A50 and (b) SAR A51. The blue square is the 
range of matrix effect from growth media Luria-Ber- tani agar.31 
 
 
1.2! Data analysis in mass spectra 
The mass spectra analysis is based on the position and intensity of the peaks when 
high volume of data is generated with noise and matrix effect. Thus, the procedure of 
filtering out irrelevant peaks, calibrating peak position and intensities, and enhancing 
meaningful signals is of paramount importance. Based on the different nature of ion 
sources and mass analyzers, the focus of data processing may differ slightly. For example, 
mass ranges lower than 1000 are usually dropped due to the matrix effect when using 
MALDI as an ion source;24 signal processing is performed in frequency domain when using 
FTMS.32 
Typically, data analysis in mass spectrometry contains two parts—signal enhancement 
and statistical analysis. The signal enhancement procedure is designed to remove noise, 
calibrate the peak intensity and pick the peaks systematically. Based on the processed mass 
spectra, statistical or machine learning methods are applied to extract characteristic peaks 































and perform sample classification and biomarker identification. The key steps of statistical 
analysis in mass spectrometry are listed and discussed below. 
 
Figure 1.5 Work flow of mass spectra analysis. 
 
 
1.2.1! Signal enhancement 
Separating the signal from noise is the primary step of signal processing. In mass 
spectrometry, the signal enhancement consists of preprocessing, which systematically 
corrects the signal away from noise; peak detection, which searches for meaningful peaks 




In order to process the data conveniently, each mass spectrum is converted into a 


















intensity. Then, the first step in mass spectra is to calibrate the information, the peaks, in a 
mass spectrum, which usually includes smoothing and baseline correction.  
 
Figure 1.6 An example of signal enhancement. (a) Original mass spectrum. (b) Mass 
spectrum after smoothing. (c) Mass spectrum after smoothing and baseline correction. (d) 
Peak detection.33 
 
Smoothing, like its name, smooths the random noises on the baseline (Figure 1.6 a, b). 
Commonly used smoothing filters are moving average filters,34-36 which average the 
adjacent points to estimate the baseline and high frequency filters such as Savitsky-Golay 
filter,35,36 Gaussian filter,35,37 Kaiser window38 and wavelet transform.39-43 After the mass 
spectra have been smoothed, baseline correction (Figure 1.6c) can be performed to balance 
the total ion intensity variance due to chemical noises and ions overloading especially in 
MALDI,44 GC-MS45 and LC-MS.46   
The strategy of baseline correction is to track the baseline profile, which usually comes 





original signal. Methods commonly used are monotone minimum,40,42 linear 
interpolation,39,47-49 Loess,47 wavelet transform41,43 and moving average of minima,50 
 
1.2.1.2! Peak detection 
Meaningful peaks can be picked up by either human-based selection or algorithm-
based selection (Figure 1.6d). Human-based selection,29,51 which is focused on unique 
peaks and mostly relies on the experience, is simple, but needs comprehensive pre-
knowledge that is not suitable for early-stage studies and data with high noise. Thus, it will 
be covered in the review. On the other hand, algorithm-based selection, which is focused 
on systematically choosing the peaks based on signal-to-noise ratio,34,36,40-42,48-50,52 
intensity threshold36,41,47,50 and peak shapes,47 simplifies the selection procedure and 
reduces the data volume for further analysis in the mass spectra.   
Peak detection and noise reduction can be coupled together. For example, peak 
selection criteria based on models35,43,53 are designed by matching peak profiles of interest 
and filter out the unmatched peaks on the mass spectra. The model, on the other hand, does 
not have to be a well-defined spectrum. Instead, the previous mass spectra of the sample 
can be used as the model to perform the matching process. Then, the peak selection is a 
correlation process, which is illustrated in Chapter 2. 
 
1.2.1.3! Normalization 
Normalization minimizes the peak intensity variance among spectra, which originates 
from instrumentation54 and chemical inhomogeneities.55 The most common method is that 
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when the original mass spectra are divided by total ion current (TIC), all the spectra will 
have the same integrated area among the spectra.55 Newly proposed normalization methods 
such as quantile normalization, group-based quantile normalization,56 cyclic loess 
normalization,57  and optimal weight factors58 are focused on the correction of peak 
distribution.  
On the other hand, vector norm (Equation 1.2, Equation 1.3) as a normalization 
method has been widely used in library searching59 and metabolomics.60 Vector norm 
denotes a mass spectrum as a vector (Equation 1.2) when p equals one (Equation 1.3); this 
is equivalent to the commonly used method, which is assigning the most dominant peak as 
100 and calculating the relative intensity of the rest peaks. When p equals two, the 
normalized mass spectrum is a vector norm or root mean square of the original spectrum. 
     Equation 1.2 
    Equation 1.3 
In addition to scaling the intensity of the peaks in the mass spectra, normalization 
methods can also be regarded as weighing procedures, which selectively and 
systematically alter the relative intensities of peaks and then weigh more on some unique 
peaks. Then, the resulting mass spectra can help to increase the efficiency of data mining 
in mass spectra, which is named power normalization and illustrated in detail in Chapter 




















1.2.2! Data mining in mass spectrometry  
With the development of high throughput profiling in samples of lipids, proteins and 
various complicated samples in the omics level study, a high volume of data has been 
generated within one mass spectrum and one sample.61,62 Data mining is a general 
description of many methods that are used to extract useful information or features in mass 
spectra. The selected features can be unique peaks m/z, or intensity or peak profiles, which 
are usually considered as biomarkers in the research. Commonly used methods are statistics, 
machine learning and algorithm design based on the needs. 
  
1.2.2.1! Feature selection and biomarker identification 
Feature selection and biomarker identification can be equivalent in mass spectra due 
to their function to find unique sets of peaks. For example, the most common types of 
biomarkers are unique molecules including protein or peptides to evaluate the severity or 
presence of some diseases,63,64 diagnostic ions in proteomics, metabolomics and 
carbohydrates study to identify the structure and function,29 and the lipid profile on the 
membrane to classify the bacteria types.31 A variety of instruments can be used to analyze 
biomarkers based on different properties, for instance western blot,65,66 
immunohistochemical staining,67,68 enzyme linked immunosorbent assay69 and mass 
spectrometry.18,70 In comparison, mass spectrometry can provide high sensitivity and 
resolution analysis for different target ions in complicated samples at molecular levels 
because it has been widely used in the research of disease studies, proteomics, 




Figure 1.7 An example of statistics analysis of biomarker identification of potential 
peptide signatures in serum samples from breast cancer mice.  The vertical scattering plot 
of peak (a) m/z 904.48, (b) m/z 1227.6,  (c) m/z 1374.75, (d) m/z 1475.80, (e) m/z 
1576.84 and (f) m/z 1821.95. * P<0.05, **P<0.01 and ***P<0.001.63 
 
In statistics, t-test and ANOVA associated with p-value comparison 63,71 is used for 
feature selection for a given set of peaks. An example of t-test analysis of biomarker is in 
Figure 1.7, in which six potential peptides are selected and the t-test is performed to identify 
the relation within the groups at different developmental stages (i.e., 0, second, fourth, sixth 
and eighth weeks). The result in the figure reveals some statistical significance between 
different groups. In order to control Type 1 error, a modified p-value comparison has been 
proposed.72 In this method, data are resampled many times to get multiple p values and 
calculated to obtain one resampled p-value, which is usually smaller than the original value. 
The statistical method is frequently used to validate potential biomarkers; however it is not 





adjusted to the optimum conditions and the candidates of biomarkers are not fully 
understood.  
On the other hand, machine learning methods classify samples first and then use the 
best classification result to weigh the most important features contributing to the result. 
These methods include supervised learning, such as decision trees, neural networks and 
supporting vector machine; unsupervised learning such as clustering; and reinforcement 
learning such as Markov decision process and game theory and various combination 
methods. Compared to the statistics method, machine learning methods that find 
biomarkers are easy to interpret and visualize without extensive pre-knowledge in selecting 
potential biomarkers; thus, these are more efficient to use in large volumes of data and in 
early stage experiments. 
 
1.2.2.2! Sample classification using machine learning methods 
Unsupervised methods in data mining classify samples without prior knowledge. On 
the other hand, supervised methods need some samples with known identities, such as the 
training group, to generate the classification boundary. Both methods are used frequently 
in sample classification in mass spectrometry. Because of the training group, supervised 
methods usually have higher classification accuracy and it is more suitable for data with 
high noise and large volume,73 which is typical for early stage experiments. Sometimes, 
unsupervised methods are used first as the feature selection tool, and the selected features 




1.2.2.2.1! Unsupervised data mining 
Cluster analysis is one of the widely used unsupervised methods. When using cluster 
analysis, each sample point is projected into a new direction, which maximizes the distance 
among the data points and highlights the differences of each sample. Then, in order to 
visualize the similarity and difference, a projection plot can be generated with two or three 
principal projection directions with the highest distance. The similar sample points are 
gathered in a project plot as a cluster (Figure 1.8).  
 
Figure 1.8 PCA score plot of 11 types of bacteria.31 
The most commonly used cluster analysis is principal component analysis (PCA), 
which uses linear orthogonal transformation of the sample points to maximize the 
difference.75 The figure below is the two-dimension PCA score plot of classification of 11 
types of bacteria;the same kind of bacteria is located relatively in a nearby cluster. Also, 
PCA can be plotted in three-dimensional figures by accounting in three principal 
component analysis.  
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Other clustering techniques have also been used commonly in the biomarker 
identification and sample classification, such as hierarchical clustering and k-means 
clustering. Figure 1.9 is a dendrogram of a typical result of the hierarchical clustering. The 
height in the vertical direction represents the distance (difference) among each cluster, and 
along horizontal axes is the list of all the samples. It usually uses Euclidean distance as the 
metric to determine the linkage of the samples at different linkage stages.76 This is 
advantageous because it uses all the information in a mass spectrum to present the linkage 
information instead of the several principal components; also it shows the cluster 
information at different stages with different precision.76 However, it is quite time-
consuming for large data sets with at least n2logn (n is the number of data points in one 
mass spectrum) times of calculation.77  
 
Figure 1.9 An example of hierarchical clustering. HER2 is human epidermal growth 
factor receptor 2, which is a criterion to therapeutic decision making in breast cancer 
patients. In this study, MALDI is used to classify breast cancer tissue, which is pre-
classified based on HER2 using fluorescence and immunohistochemical analysis.76 
 
K-means clustering is another type of cluster analysis. In contrast to the previous 
analysis, it pre-sets a fixed number of clusters, k, and partitions all the samples to k clusters 
so as to minimize the inter-cluster distance. Because the total number (k) of sample types 
is known, the result has been improved compared to previous methods.73   
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Also, the selected principal scores in cluster analysis can be post-processed to 
calculate one value, which is plotted by pseudo-color code (Figure 1.10). Thus, in the figure, 
each pixel is a combination of the cluster score calculated. This technique is called spatial 
segmentation and is used widely in mass spectrometry imaging.  
 
Figure 1.10 (a) Optical image (b) Straightforward k-means clustering of spectra. (c) 
Hierarchical clustering followed by PCA reduction of the original spectra.78 
 
1.2.2.2.2! Supervised data mining 
In supervised classification for mass spectrometry, samples are usually randomly 
separated as training group and testing group, where the training group is used to 
generate or modify classification criteria and the testing group is used to evaluate the 
performance of the classifier. The commonly used supervised methods in mass 
spectrometry are linear discriminant analysis, k-nearest neighbor, random forest, neural 
networks and supporting vector machine. 
Linear discriminant analysis (LDA) was first proposed by Fisher79 in 1936. Based on 
the assumptions that all the groups have a normal distribution of the data points, it finds a 
linear combination of all the m/zs that maximize the inter-group difference and minimize 
the intra-group variance. Due to its simplicity, it has been used in the study of proteomics,80 
cell wall profile81 and metabolomics.82 On the other hand, k-nearest neighbor (kNN) is 
another simple supervised method, which was used frequently in the mass spectra studies 




and the identity of the unknown is determined by the percentage of each group within the 
k samples. An illustration of using kNN where k is 10 to determine the identity of unknown 
“X” among three kinds of groups (type1, type2 and type3) is shown in Figure 1.11a. When 
using Euclidean distance (using circles to embrace samples), ten nearest samples are 
selected and the identity of unknown is type 2 via counting the samples. Due to simple 
assumption and model of the classification, both LDA and kNN need to do a peak reduction 
procedure before actually achieving an acceptable classification result,85,86 which 
sometimes may introduce bias and unstable error rate.73 
 
Figure 1.11 (a)An example of kNN where k is 10. “X” is the location of unknown sample 
and the black circle is the calculated neighbors of “X” using Euclidean distance. (b)A 
scheme of  random forest for sample classification in mass spectrometry. 
 
A different classification method is random forest, which consists of many decision 
trees. Just as its name indicates, a decision tree has many nodes and branches, where each 
branch is a classification criteria and each node is a result (Figure 1.11b). Because the 
criteria for each decision tree is very limited, the random forest gathers the result of 
multiple trees and uses panels to vote for a final result. This method is relatively 
complicated because many classification criteria are used; when input peaks are larger than 























the number of training samples, the amount of calculation is huge, although it is stable 
regarding error rates.73 
Even though artificial neural networks (ANN) can be used in a supervised and 
unsupervised way, the supervised method with training groups is more favored by 
researchers in mass spectrometry due to higher classification accuracy.73,87,88 The simplest 
ANN has three layers: the input layer, which is the sample data, the output layer, which is 
the category of the data, and the hidden layer, which is the fitting relation between the input 
and output (Figure 1.12a). When using an ANN, sample data are automatically divided into 
training, validating and testing. The advantage of ANN is the learning procedure, which by 
each time of the validating, the coefficient in the fitting will be adjusted to improve the 
classification efficiency.89 The disadvantage is that multiple trials and experiences are 
needed to set up the number of layers, which is usually set to 1 in most studies and the 
learning procedure is relatively time-consuming for large data sets.73,90 
 
Figure 1.12 (a)A type design of ANN with two inputs, one hidden layer and one output. 
(b) Illustration of using supporting vector machine to classify mass spectra. The vector is 
mapped into a high dimension space, where a classification boundary is generated using 









































Compared to other methods, the supporting vector machine has the most tolerance 
for low quantities of samples and high volumes of data within one sample spectrum.73,91 
SVM projects the training data into a high dimension space in which a maximum-margin 
hyper-plane can be found to classify two groups. It then projects the testing data on the 
same space to predict the category (group) of the sample based on the position relative to 
the hyper-plane (Figure 1.12b). For classifying more than two types of samples, a “one-
against-one” multi-class SVM is required to differentiate each two classes.92  
Every algorithm has its disadvantages and advantages. Many of the studies found 
that the classification result has no statistically significant difference when using different 
methods.73,90. However, the other studies found one has a better performance.73,90 Thus, the 
result is highly dependent on the nature of the data and the algorithm mechanisms. Most 
of time, because simply applying one method cannot achieve optimum performance, 




Mass spectrometry has been widely used in the analysis of trace-level molecules in 
complicated samples such as blood, urine and food. Due to high sensitivity and high 
variation in the mass spectra, especially in early stage experiments, picking up meaningful 
information and filtering out the matrix effect and background noise have paramount 
importance.  
A typical data processing procedure in mass spectrometry includes the two steps: the 
first is the prepossessing, which is designed to filter out the noise and calibrate and enhance 
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the peaks on a general level; the second step is data mining, which is used to extract the 
important information such as characteristic peaks, peak relations and profiles, which can 
be further identified as biomarkers. Any advanced algorithms cannot guarantee an 
optimum classification because they are highly dependent on the data property, including 
the matrix effect, intensity and variation.  
This thesis features a data prepossessing algorithm, self-correlation, in Chapter 2, 
which is ideal for Fourier transform mass spectrometry while collecting signals in the 
frequency domain. Based on the practical uses, including the convenience of data 
collecting and usage of internal standards, three scenarios consisting of broadband MS 
analysis, selected ion monitoring and intra-SC using a single data set have also been 
proposed.  
Chapters 3 and 4 are focused on algorithm development especially for the early stage 
experiment, which has a high matrix effect and low sample quantity.  Regarding the high 
matrix effect and intensity variation, power normalization is proposed to automatically 
assign optimum weighing factors to the peaks on the mass spectra.  In addition, 
classification errors have been considered to increase the classification accuracy by 
calculating the probability. Also, different classification methods have been compared to 
the final choice of SVM due to its capability to handle low sample quantity. Though the 
methods proposed are based on the application of mass spectra, they are capable of solving 
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CHAPTER 2.!SELF-CORRELATION METHOD FOR PROCESSING RANDOM 
PHASE SIGNALS IN FOURIER TRANSFORM MASS SPECTROMETRY 
2.1! Introduction.  
Mass spectrometry (MS) provides high specificity and sensitivity for chemical 
analysis and the mass analysis can be performed through a variety of methods. Fourier 
transform mass spectrometry (FTMS) has been traditionally implemented with ion 
cyclotron resonance (ICR)1,2 and later with Orbitrap mass spectrometers,3 which provide 
high resolution and high mass accuracy. The motion frequencies of the trapped ions are 
detected through the image current measurement1,4-6 followed by the Fast Fourier 
Transform (FFT).1,3,7-10 As an alternative and non-destructive mass analysis method, 
Fourier transform mass analysis has also been explored for ion trap mass 
spectrometers.4,5,11 Recently it has been performed at high pressures (up to 50 mTorr) using 
a constant excitation while measuring a non-decaying harmonic motion of the ions.12   
In FTMS, dedicated electronics are typically developed and used to control the phases 
in ion excitation and signal recording13-15 because random phases result in a decrease in the 
efficiency for signal enhancement using common data processing methods such as 
averaging. The signal-to-noise ratio (SNR) can typically be significantly improved through 
the averaging of data sets with the signals in the same phase; however, averaging of two 
data sets with different initial phases (with the reference to the ion excitation) of the 






Figure 2.1 Averaging of data sets without signal phase control. Data sets (a) and (b) 
(green) with signals (black) of different initial phases and white Gaussian noise (WGN). 
(c) The averaged data set. The corresponding spectra after FFT shown in (d) and (f). 
 
In addition to the phase control during the data recording, different algorithms have 
been explored to extract the phase information of the signals in data sets, which can be 
used in the subsequent steps in the data processing.16-23 Improvements in the resolution and 
SNR in Fourier transform MS can be achieved using methods such as absorption mode,16-
24 data reflection,25, and Hartley/Hilbert transform,26 etc., with the phases identified for 
signals in the data sets. However, finding the signal phases accurately can be difficult and 
the methods for doing so are typically mathematically complicated. Other methods have 
also been developed for processing data of different phases without requiring the extraction 
of the phase information, such as magnitude-mode derivation,27,28 autoregression model,29 








transform.31 These methods perform a direct process of the data, but sometimes can require 
long computation time and can have artifacts induced in the processed signals.25 
When FTMS was applied using ion trap, the image current measurement suffers from 
the interference by the trapping RF signal4,5,11 as well as the fast decay of the coherent ion 
trajectories.5,7,32 In comparison with other mass analyzers, ion trap has an advantage of 
trapping and mass analyzing ions at relatively high pressures (>1 mTorr);33,34 however, the 
amplitudes of the ion motions decrease significantly in a short period of time (< 1ms )1 due 
to the collisional cooling with the background gas molecules.  Using a constant excitation 
to sustain the coherent ion trajectories while measuring the harmonic motions, FTMS have 
been successfully performed at 1-50 mTorr. A narrow band filter has been used to minimize 
the interferences due to the trapping RF and the excitation AC signals.12  It is highly 
desirable to implement a broadband FTMS with ion trap for a simultaneous detection of 
ions over a wide m/z range, while this remains an interesting challenge with the 
requirement of a significant enhancement of the SNR and with a difficulty in the 
availability of the high quality wide-band filters.  
In this study, we explored a method for processing data of random phases using a 
simple algorithm based on the self-correlate (SC) function. Correlation function was first 
developed by Norbert Wiener in 194935 and has been previously introduced for information 
analysis with mass spectrometry data,36 such as the identification of isotope distribution37,38 
or search of ion fragments in standard libraries.39  Here we investigate the possibility of 
applying SC method for improving the SNR in the FTMS spectra using data acquired at 
random initial phases by image current measurements. Though the data used in the 




data previously collected for FTMS using an ion trap,12 the demonstrated capability of the 
SC methods should also be applicable to data recorded using ICR or Orbitrap. 
 
2.2! Algorithm 
2.2.1! Self-correlation in the FTMS with random phase  
Assuming S(m1) and S(m2) are the two sets of data recorded at different phases through 
image current measurements and each contains m1 and m2 data points, the mathematical 
model of SC function is defined as 
 SC(m1 ,m2 )= E{S
*(m1 )S(m2 )}              Equation 2.1 
where E is the expectation. The data recorded is a combination of the signal V at a random 
phase Φ and a white Gaussian noise (u), which the expectation of u(m), E(u(m)) is zero. 
Then, Equation (1) can be converted to 
 SC(m1,m2 ) = E{[V (m1,Φ)+ u(m1)]
* × [V (m2 ,Φ)+ u(m2 )]}        Equation 2.2  
where Φ is the function of a homogeneous distribution between (0, 2π). Assuming that the 
noises and signals are independent, Equation 2.2 canbe expanded as 
 
SC(m1,m2 ) = E[V (m1,Φ)V (m2 ,Φ)]+ E[V (m1,Φ)]E[u(m2 )]+ E[V (m2 ,Φ)]E[u(m1)]
                     + E[u(m1)]E[u(m2 )]= E[V (m1,Φ)V (m2 ,Φ)]
 
Equation 2.3 
The phase Φ is random with a homogeneous distribution between (0, 2π) and the 




!!!!!0≤ϕ ≤2π        Equation 2.4  




at one frequency f, V(m, Φ) can be written as 
V (m,Φ) = Asin(2π fmT +Φ)                     Equation 2.5  
The expectation µv(m) of V(m, Φ) can be calculated as 
 
µV (m) = E{Asin(2π fmTs +Φ)}






                Equation 2.6  
Then, the Equation 2.3 can then be written as 
 
SC(m1,m2 ) = E{A
2 sin(2π fm1Ts +Φ +ϕ0 )sin(2π fm2Ts +Φ)}
                = A
2
2π
sin(2π fm1Ts +ϕ +ϕ0 )sin(2π fm2Ts +ϕ )0
2π
∫ dϕ
                = A
2
2
cos[2π f (m2 − m1)Ts +ϕ0]
          Equation 2.7  
where φ0 is the initial phase of S(m1).  
Similarly, for data containing signals at more than one frequency, the SC function can 
be written as 
 
SC(m1,m2 ) = E{[A1 sin(2π f1m1Ts +Φ +ϕ0 )+!+ An sin(2π fnm1Ts +Φ +ϕ0 )]
                ⋅[A1 sin(2π f1m2Ts +Φ)+!+ An sin(2π f2m2Ts +Φ)]}
    
Equation 2.8  
After the two data sets are processed with the SC method, a new data set with (m1+ 





2 cos[2π fikTs +ϕ0]
i=1
n
∑                    Equation 2.9  
where Ai (with i =1 to n) is the amplitude of the ion motion at frequency fn , k = (0, 1, … 
(m1+ m2 )), Ts is the sampling interval, and φ0 is the initial phase of S(m1).  
Based on Equation 2.9, several conclusions can be drawn for the SC method: a) the 




is applied (Ai to Ai2/2); c) difference in phase of the data is eliminated, with the phase of the 
processed data being the same as that of the original data set S(m1).  
The Equation 2.9 is derived based on the assumption of the independence among the 
noises and the independence between the noises and the signals. However, the correlation 
coefficients might not always be 0 in a real case, which could result in a relatively high 
background noise in the processed spectra after SC. Thus, in a real case the noises might 




( Ai + riσ )
2 cos[2π fikTs +ϕ0]
i=1
n
∑ + r0σ 2             Equation 2.10  
where ri and r0 are constants indicating the correlation coefficient between the signal and 
noise and among the noises, respectively. They are dependent on the randomness of the 
noise. If the data sets are of a same length, a fast SC can be performed,36 which highly 
reduces the calculation time. It is done by first getting the FFT of both data sets as defined 
below: 
 F[SC(m1,m2 )]= F[S(m1)]⋅F[S(m2 )]
*                    Equation 2.11  
As a simple demonstration of the SC method, two data sets, Data I (Figure 2.2a) and 
Data II (Figure 2.2b), are generated with ion motions at two different frequencies at 110 
and 120 kHz. Gaussian white noises (WGN) have been generated to simulate the signals 
recorded using image current measurement in a previous study.12 These two data sets have 
initial phases with a difference of π/2. Applying SC for one time (noted as SC1) with Data 
I and Data II, the result obtained is shown Figure 2.2c, with the SNR significantly 
improved for the peaks in the spectrum in frequency domain. After SC1, the amplitude is 




multiple times (noted as SCn) with additional data sets, which will be further discussed 
later in this manuscript. 
 
Figure 2.2 Data I (a) and Data II (b) contains signals at 110 kHz and 120 kHz with a 
difference of π/2 in initial phases and random Gaussian white noise. (c) The data set and 
spectrum obtained after processing with SC method. 
 
2.2.2! Calibration of relative intensity 
While the SNR is improved, the ratio of the relative intensities of the two peaks is also 
changed by a square factor.  The relative abundances of ions in mass spectra are important 
since they represent the relative concentrations of the analytes in the original mixture. It is 
also an  important  practice to add  internal standards  (IS) into the samples  and to use the































































relative analyte-to-IS ratios for quantitation. The change in the peak ratio after the SC can 
be corrected by getting the square root of the processed intensity of each peak.   
Assuming analytes A has the dominant peak which is normalized to a intensity of 
100 in the mass spectra, if the intensity of a lower peak B is noted as B0 before SC, and 
























Thus, B0 is calculated as 
 B0 = Bn ⋅100
nn+1
                    Equation 2.12 
Thus, Equation S12 is transition function is derived to express the relationship 
between the intensities of the peak for B before (B0) and after (Bi) applying SC i times 
2.2.3! Calibration of signal-to noise ratio 
In a spectrum with high background noise, both B0 and Bn are summations of the noise 
and the signal. Assuming the noise level IN after the SCn is 
 IN =σ n + µn                           Equation 2.13 
where σn and µn are the standard deviation and the average of the noise, respectively. 








             Equation 2.14 














(100+ IN )Bo −100IN
      Equation 2.15 
which represents the intensity ratio between the two compounds (A/B) in the mixture. The 
accuracy of the peak ratio can be calculated with  
 
Pr % =
| Re − Rreal |
Rreal
100%                      Equation 2.16 





                    Equation 2.17 
where V is the signal related to ion motions and U is the noise, and norm means the 
normal number of the whole data sets (V or U), which indicates the energy of the signal 
or noise. For the peaks in the spectra based on the data processed wtih SC method, the 
observed signal-to-noise ratio is defined as  
        Equation 2.18 
where the IP is the intensity of the peak and IN is the noise level, which both are measured 
directly from the spectra.  
 
2.3! Data simulation 
The generation of the simulated data sets and the processing of them with SC method 
were implemented using home written programs in MatLab (version R2010a, MathWorks, 
Natick, MA, USA,). The original data sets were simulated based on the experimental data 
previously recorded for image current measurement using a linear ion trap at pressure as 








motion at relatively low q (low potential well depth) and a space charge effect.  
To generate the simulated data sets S(m1), S(m2), S(m3), and S(m4), the spectra in the 
frequency domain were first generated as shown in Figure S1c, with 524,289 data points 
covering a frequency range from 0 to 250 kHz, corresponding a sample rate of 5 MHz 








2 +φ,m∈[mstart ,mend ]      Equation 2.19 
where mstart and mend are the sequence numbers of the start and end data point of a peak, 
and ϕ is the initial phase of the data set (with a reference to the ion excitation).  For the four 
data sets generated, the initial phase ϕ was selected as 0, π/3, π/2, π.  A reverse Fourier 
transforms was then applied to the process data set to generate a data set in time domain 
with 1, 048, 576 data points. 
A RF of 580 kHz and 188 Vpp was used for the measurement and a sampling rate of 5 
MHz with a resolution of 5 Hz was used. The secular frequencies of protonated cocaine 
ion m/z 304 and protonated atenolol ion m/z 267 under these conditions were 123.88 kHz 
and 145.04 kHz, respectively. The ratio of the relative intensities of these two ions was 
10:7. Four data sets, S(m1), S(m2), S(m3) and S(m4), were generated for 200 ms image 
current measurements with different initial phases at 0, π/3,π/2 and π but all with a same 






2.4! Result and discussion 
2.4.1! Broadband MS analysis 
Through a broadband excitation and a subsequent image current measurement, ions in 
a wide m/z range can be detected simultaneously. In the simulated data sets, S(m1), S(m2), 
S(m3) and S(m4), the original peak ratio Rreal for protonated cocaine to atenolol was 1.42.  
Applying SC once to S(m1) (Figure 2.3a) with S(m2) (Figure 2.3b), the SC1 spectrum in 
frequency domain was obtained after Fourier transform as shown in Figure 3c.  In 
comparison with the spectra obtained from original data sets (insets in Figure 3a and 3b), 
the peaks can be much better observed in the SC1 spectrum (Figure 2.3c). The SpNpR has 
been increased from 1.9 to 3.5 for atenolol (m/z 267 at 145.04 kHz) and from 2.5 to 5.7 for 
cocaine (m/z 304 at 123.40 kHz).  After SC was applied for additional two times with data 
set S(m3) and S(m4), future improvements in SpNpR were obtained (Figure 2.3d) with SpNpR 
= 29.8 for atenolol and 83.3 for cocaine. The SpNpR as a function of times of applying SC 






Figure 2.3 Data set S(m1) (a) and S(m2) (b) with two signals at 123.88 kHz and 145.04 
kHz, -25 dB white noise in time domain (c) SC1 spectrum obtained after applying SC 
with S(m1) and S(m2); (d) SC2 spectrum obtained after further applying SC with S(m3). (e) 
Improvement of the SpNpR for protonated cocaine ion m/z 304 at 123.88 kHz and 
atenolol ion m/z 267 at 145.04 kHz as a function of times of applying SC. (f) The 
improvement of accuracy for peak intensity ratio. 
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As discussed above, the preservation of the peak ratios or relative intensities is 
important for quantitation. The impact of applying SC on the peak ratios has also been 
evaluated.  The peak ratio Re was calculated with the observed intensities each time after 
applying the SC method, which are 1.25, 1.33, 1.36 and 1.37 for SC1, SC2, SC3 and SC4 
spectra, respectively.  As shown in Figure 3f, the accuracy of the peak ratio Pr increased 
from below 85% for the original spectrum to above 95% for the SC4 spectrum. The 
observed intensity of each peak in a spectrum is the summation of the intensities of the 
noise and the real signal.  The improvement of the SNR through the SC method hence leads 
to more accurate peak ratios calculated based on the observed peak intensities. 
 
2.4.2! Selected ion monitoring 
In the selected ion monitoring mode, the abundance of ions at a particular m/z value 
or the intensities of peaks within a narrow range of frequency are monitored. This can be 
applied for the selected reaction monitoring (SRM) for monitoring a specific fragment or 
reaction product ion. Since the m/z value and the corresponding frequency of the ion to 
be monitored are known, a “mask” data set can be generated for to perform a selective 





Figure 2.4 (a) Data set S(m1) with two signals at 123.88 and 145.04 kHz for protonated 
cocaine m/z 304 and atenolol m/z 267,with -25 dB white noise in time domain; (b) Mask 
data set with signals of equal intensities at 123.81, 145.04, and 150.55 kHz. (c) SC1 
spectrum for monitoring selected ions by applying SC with the mask data set and S(m1). 
(d) SC4 spectrum obtained by applying SC to the mask dataset with S(m1), S(m2), S(m3) 
and S(m4)  (e) Spectrum of a simulated data with -40dB WGN and (f) SC4 spectrum 
obtained after applying SC to the mask data set with three data sets. 
 
As an example, the simulated data S(m1) for image current measurement (Figure 2.4a) 














































































































































is correlated with a mask data (Figure 2.4b). The mask data set is designed for a 
simultaneous monitoring of protonated atenolol m/z 267 and cocaine m/z 304 under the 
experimental conditions described above. The mask data set contains frequency 
components with equal amplitudes of 100 at 123.81 kHz and 145.04 kHz for sampling 
signals of ions at m/z 267 and m/z 304, respectively (inset in Figure 2.4b). A third frequency 
component at 150.55 kHz (corresponding to m/z 260) is used to sample the noise, with an 
assumption that there are no analyte ions at m/z 260. Applying the SC to the mask data set 
with the simulated image current data set S(m1) (Figure 2.4a), an SC1 spectrum was 
obtained after FFT as shown in Figure 4c. In comparison with the original spectrum (inset 
in Figure 2.4a), the SpNpR was much improved after the data processing.  
The peak at the 150.55 kHz serves as the indicator for the noise level in the processed 
spectrum, which decreased from 100 in the original mask spectrum to 15 in the SC1 
spectrum.  Further reduction of the noise was achieved by applying SC with additional data 
sets S(m2), S(m3) and S(m4), and the noise level was reduced to 2.7.  The peak ratios and 
their accuracies were also calculated and a trend of the Pr was similar to that shown in 
Figure 2.3f.  
As a demonstration of the capability of applying SC with the mask data set for selected 
ion monitoring, four data sets similar to S(m1), S(m2), S(m3) and S(m4), but all with a much 
lower SNR of -40dB were generated for the data processing.  A spectrum for one of the 
original data set is shown in Figure 2.4e, in which no peak can be observed due to the poor 




with significantly improved SpNpR was obtained as shown in Figure 2.4f.  The accuracy of 
the peak ratio was calculated as 96.7% for the SC4 spectrum. 
 
2.4.3! Intra-SC using a single data set 
In addition to applying the SC with multiple data sets collected at different times, the 
effectiveness of applying SC to multiple subsets extracted from a single long data set was 
also explored.  The S(m1) data set for 200 ms image current measurement was equally 
divided into multiple subsets for testing the data processing using SC.  The SC1 spectrum 
with 2 subsets (from one equal division of S(m1)) and the SC9 spectrum with 10 subsets 
(from 9 equal division) are shown in Figure 2.5a and Figure 2.5b, respectively.  A 
significantly better SpNpR was obtained for the SC9 spectrum.  The SpNpR and the peak 
ratio accuracy are plotted as functions of the number of subsets from equal divisions of 
S(m1).  While the SpNpR increases monotonically with the number of the divisions (Figure 
2.5c), the peak ratio accuracy has been shown to be the best with three subsets divided 
from the original data (Figure 2.5d). The optimal number of the divisions of a data set is 
expected to be dependent on the SNR and overall length of the original data set, but not 







Figure 2.5 (a)SC1 spectrum with two data subsets from S(m1).  (b) SC9 spectrum obtained 
by dividing S(m1) into 10 subsets. (c) Improvement of the SpNpR for protonated cocaine 
m/z 304 at 123.81 kHz and atenolol  m/z 267 at 145.04 kHz and (d) the variation of the 
accuracy in the peak intensity ratio as a function of the number of the data subsets. 
 
Splitting a long data set into subsets theoretically can result in a poorer resolution in  
the processed spectrum, since the FFT is applied with a shorter processed data set.  As an 
example, the limit of the spectral resolution in frequency domain changes from 5 Hz to 50 
Hz when a 200 ms data set is split into 10 subsets. However, in a real case where the peak 
broadening is mainly due to other factors, such as space charge effect, no significant 
broadening due to the shortening of the data set for FFT may be observed. 
 

















































































The signal enhancement using self-correlation method has been proposed for 
processing random phase signals in Fourier Transform Mass Spectrometry. It is performed 
by correlating two sets of signals to identify the similar pattern and to generate a new data 
set with the identified pattern of reduced random noise. The SC method can be used in non-
targeted, broad band and wide mass range ion detection as well as the targeted ion detection. 
The improvements in the signal-to-noise ratio and the peak ratio accuracy have been 
demonstrated. Though data sets of equal lengths were used for discussion in this paper, the 
SC method can also be applied among data sets of different lengths using the same 
procedures. The noise in the longer data set is expected to have more impact on the 
processed data than the noise in the shorter ones. The data simulated based on the ion trap 
FTMS were used for the characterization of SC method in this study; however, the general 
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CHAPTER 3.!STATISTICAL ANALYSIS MODEL OF CLASSIFYING STEREO 
STRUCTURES OF OLIGOSACCHARIDES USING TANDEM MASS 
SPECTROMETRY— AN EXAMPLE OF USING POWER NORMALIZATION 
FOR MASS SPECTROMETRY DATA ANALYSIS AND ANALYTICAL 
METHOD ASSESSMENT 
3.1! Introduction 
Oligosaccharides, associated with lipids and proteins, play an important role in the 
biological systems such as construction of plasma membrane, cell signaling and cell-cell 
recognition1,2. Thus, an increasing interest has been put into the study of the structure of 
the oligosaccharides including linkage, anomeric configuration and sugar type. Mass 
spectrometry with ability of providing detailed molecular information and high sensitivity 
has been generally used in study of sample identification. Associated with tandem mass 
spectrometry (MSn), the difference of structure can be revealed in the difference fragment 
pattern of diagnostic ion.  
Identification of oligosaccharides has difficulty in the highly repetitive unit with 
similar mass over charge ratio (m/z). Previous study shows that structure information, 
including non-reducing sugar type and anomeric configuration of oligosaccharides, can be 
identified by ion trap collision-induced dissociation (CID) with controlled collision 
energy3,4. D-aldohexose-glycolaldehydes (GA, Figure 3.1a) of 16 types has been 
synthesized for comparison. Accordingly, sugars (e.g. disaccharides, Figure 3.1d) with 16 




alt, α-D-gal, β-D-gal, α-D-glc, glc-β-D-glc, α-D-glu, β-D-glu, α-D-ido, β-D-ido, α-D-man, 
β-D-man, α-D-tal, β-D-tal) can potentially be classified by the fragment pattern (Figure 
3.1c) from diagnostic ion (diagnostic ions m/z 221, C8H13O7-, Figure 3.1b)3,4. Glyco-
bonds of oligosaccharides are highly sensitive to the collision energy input, thus, for each 
time, the collision energy should be adjusted to acquire to same ratio of base product ion/ 
precursor ion. 3,4 The whole process is time-consuming and labor intensive. 
 
Figure 3.1 (a) One example of synthesized standards α-D-Glcp-GA. (b) Diagnostic ion 
m/z 221 is used as parent ion of fragment patter (c) in classification. (d) One example of 
ionized disaccharides α-D-Glcp-(1-4)-D-Glc, m/z 341. Diagnostic ion can be got after 
CID. 
 
There are many commercially available or published tools for interpreting mass 
spectra data of carbohydrates or mass spectra-based biomarker identification.5 
Commercially available databases and libraries6-8, self-synthesized standards3,4 and 
extensive publications provide references to match the experiment mass spectra to specific 
species.  
In the matching process, conventional software of carbohydrates9-12, proteomics13,14 







absence of a set of characteristic peaks.  Algorithm of peak matching is one of them, which 
counts a set of unique peaks between sample spectra and all reference spectra with certain 
tolerance and ranks the counting score to make a judgment (one algorithm of peak 
matching11 is shown in Equation 3.5).  
On the other hand, intensity-based techniques, which include both intensity and mass-
over-charge ratio of peaks, can improve identification accuracy due to intensity-structure 
relation has been considered16,17. Statistical methods such as standard deviation18, t-test19 
and ANOVA20 can be used to perform intensity-based peak-level identification, in which 
peaks should be pre-selected for analysis. Recently, peak profile has been used for sample 
classification and biomarker identification by using pattern recognition methods or 
machine learning methods, for example dot product21, principal component analysis 
(PCA)22, supporting vector machine (SVM)23, decision tree24 and neural networks25. Due 
the profile analysis contains all the mass spectra information including existences, 
intensities or the relative intensities in the mass spectra, it receives prospective results and 
simplifies the procedure in peak-by-peak analysis.  
Profiling-based sample classification and biomarker identification are dependent on the 
significance set for the peaks in the statistical methods. Typically higher weights are given 
to peaks of higher-intensities, which thereby make them of higher contribution to the final 
decision16,26,27.  In analysis of complex samples, the major peaks of the potential 
biomarkers, however, can be suppressed by the chemical noise due to other compounds in 
the sample matrix and their intensities can be of relatively low levels.  Its negative impact 




interest based on previous knowledge.  This, however, can introduce errors for the data 
analysis due to the bias. 
In this study, we explored a method for performing a systematic evaluation of the mass 
spectrometry data for sample classification and biomarker identification.  The outcome can 
also be used to assess and optimize the analytical approach at an early stage of a study. A 
distinct feature of this method was the power normalization of the peak intensities prior to 
the sample classification, which was done using SVM in this study. Power nominalization 
index (PNI, to be further described) was varied to systematically rescale the intensities of 
all the peaks and the subsequent impacts on the sample classification were analyzed. We 
also introduced the error-PNI count plot, which revealed the relationship between the 
power normalization and the errors in sample classification and more importantly, served 
as a high level summary of the possibility in distinguishing the samples using the particular 
analytical procedure.  
The nature of the samples and the quality of the data can vary significantly at different 
stages of a study.  For example, at the early-stage of the study a major aim typically is to 
develop and optimize the analytical method that can deliver high quality spectra for 
efficient sample classifications. At this stage, the number of biological samples can be 
limited and adequate knowledge about the samples might not be available to allow an 
arbitrary selection of peaks or mass ranges for data analysis without a significant bias. Data 
analysis providing a comprehensive evaluation of the experimental method is particularly 
important for the rapid and effective development and optimization of the analytical 




The statistic model can not only use to classify oligosaccharides based on the fragment 
pattern of the non-reducing end has been proposed, but also can be used to guide the 
method development for biomarker identification at early stage using mass spectrometry. 
In addition to the evaluation of early-stage experiment, based on the PN-SVM results, the 
possibility of experiment selection of characteristic peaks, ranking of similarity, 
comparison between different methods and the effect of experimentally energy control in 
data analysis are discussed as well.  
 
3.2! Method 
In order to process the mass spectra efficiently, each mass spectrum was converted 
into a vector of multiple dimensions, with each dimension corresponding to a particular 
mass-to-charge ratio (m/z) with a magnitude assigned as the peak intensity at the m/z value. 
The power normalization was applied for each spectrum first, at a PNI value, and the mass 
spectra for each sample category were then divided into the training and testing groups.  
The classification was done using a multi-class SVM (support vector machine). The 
training groups were used to generate the model with classification boundaries, while the 
testing group was used to evaluate the classification accuracy using the model.  The SVM 
method has been shown to be powerful in classifications with lower number of samples28, 
which is particularly suitable for early-stage studies with limited number of samples 





3.2.1! Multi-class SVM  
SVM projects the training data into a high dimension space which a maximum-margin 
hyper-plane can be found to classify two groups, then projects the testing data on the same 
space to predict the label (group) of the sample based on the position relative the hyper-
plane (Figure 3.2). For classifying 16 types of oligosaccharides, a “one-against-one” multi-
class SVM is required to differentiate each two classes29.(Equation 3.1)  
 
min
ω ij ,bij ,ξij




Tω ij +C (ξij )t
t
∑
 subject  to     (ω ij )
Tφ(xt )+ bij ≥1−ξij ,t ,  if  x t  in the ith class,
                      (ω ij )
Tφ(xt )+ bij ≤1+ ξij ,t ,  if  x t  in the jth class, 
                      ξij ,t ≥ 0
 
Equation 3.1 
where ω is the normal vector of the hyperplane, i and j represent ith or jth class in the multi-
class classification problem, C is a regularization parameter which is typically set as 1 for 
oligosaccharides data, t indicates tth sample data, ξ is a slack variable which measures the 
misclassification of trainings which ideally equals 0, b is the intercept or offset of the 
boundary,φ(x) projects the data into the high dimensions and is a part of the kernel function 
that meaures the similarity. Different kernel functions are tested with 16 stardards including 
linear kernel, polynomial kernel, radial basis kernel and sigmoid kernel. No obvious 





Figure 3.2  Workflow of oligosaccharides classification using SVM. Each spectrum is 
converted to a vector after prepossessing. The vector is mapped into a high dimension 
space, where a classification boundary is generated using the maximum margin by 
training data. 
 
3.2.1.1! Decision scores of classification --sum of distance 
Decision score is calculated to rank the similarity of the unknown sample to all the 
possible sample types. Conventionally, it is calculated by the sum of voting between each 
two groups. During this process, the sample type which is more similar to the unknown 
will be voted as “+1” and the type getting the highest vote will be considered as predicted 
group of the test data. Thus, each testing data will undergo k(k-1)/2 times of pairwise binary 
classification process based on decision value (Figure 3.2), where k is the number of the 
categories. 
While with number of groups goes up to 3, the voting ranking remains a problem. For 
example, in the study, there are 16 different kinds of sugars, which means only 16 voting 



























































As a result, the irrelevant group may be voted even higher than the expected one. Here, we 
use sum of distance to calculate the decision score for different samples. Simply, it is 
calculated using the sum of distances (D, the decision score) between the testing sample 
and all the classification boundaries for different sample types. This works particularly well 
for evaluating the initial analysis in an early-stage study, where the number of possible 
sample types is typically larger than the replicates of each sample type. 




where ω is the normal vector of the hyperplane. The larger is the distance, the further is the 
data point away from the classification boundary, which means a higher possibility for 
correct assignment of the sample to the corresponding group. The numerator [ωijφ(xt)-bij] 
in Equation 3.2 is called the decision value. Sometimes, ranking might be achieved by 
simply using ωijφ(xt).30 However, it can only be done in this way when the number of 
sample types is limited and properties of training set are similar enough, so b and |ω| can 
be ignored. 





ω ij ⋅φ(xt )− bij
ω ij
Dtm = dij
j, if  i=m
∑ − dij
i, if  j=m




where n is the total number of the sample types in the classification. The calculated decision 
values D can be used to support a variety of data analysis, such as the similarity ranking of 
all the possible sample types for testing sample as well as the ranking of the characteristic 
peaks that contribute the most to the classification. 
 
3.2.1.2! Ranking of similarity and selecting characteristic peaks 
Ranking similarity is simply ranking the decision score in Equation 3.3. For example, 
in carbohydrate study, there will be 16 decision values corresponding to 16 possible groups 
for the test sample. The group with the highest decision value is considered as the one that 
is most similar to the unknown. 
The normal vector ω (Equation 3.1) is the coefficient of the mathematical combination 
of all the elements in the vector transformed from mass spectra. It is calculated to draw a 
classification boundary to largely separate different groups in the nearby area. Thus, the 
procedure of finding characteristic peaks is to find the largest coefficients is the ω, which 
contributes most in calculating the classification boundary. Choosing different kernel 
function may result in different ranking of characteristic peaks. However, when the number 
of training sets is very small compared to the dimension of input spectra vectors, the 
difference can be ignored. 
 
3.2.2! Power normalization 
The power normalization was used to adjust the weights of the peaks at different 
intensity levels for the classification.  It was performed by scaling the intensity of all the 





      
Equation 3.4 
where peaki is the original peak intensity of the ith peak in the spectra and Peaki is the scaled 
intensity after the power normalization. The denominator, the square root of the sum of 
squares of all the peak intensities, was used so to achieve an energy balance in every 
spectrum. As shown in Figure 3.3, the normalization at a PNI changed the relative 
difference in contribution to classification between peaks of high and low intensities. 
Normalization with a PNI lower than 1 reduced the difference, while granting higher 
weights to the peaks of lower intensities. For example, the fragment patterns in the MS/MS 
spectra (Figure 3.3c, d) recorded for two synthesized monosaccharaides3,4, ido-α-GA and 
glc-β-GA, were very simliar. After rescaling the spectra with a power normalization at PNI 
of 0.3, the peaks previously hidden now stood out (Figure 3.3a, b).  A further analysis using 
SVM identified that these peaks originally of low intensities made critical contribution in 











Figure 3.3. Mass spectra of ido-α-GA(a) and glc-β-GA(b) normalized with  power index 
0.3. The original mass spetra of ido-α-GA(c) and glc-β-GA(d) before power 
normalization. (e) The weighing factor of different intensities with different power index. 
 
3.2.3! Other techniques 
Peak matching counts the number of peaks with same m/z value of two spectra. The 
higher the score is, the more similar the two spectra are. There is no standard formula for 
















































































where Ps is the m/z of input peak, Pr is the m/z of reference peak in the library, Err is 
the tolerance (in mDa) and n is the number of input peak. Peak matching considers only 
the information of present peaks without intensity, thus it may be sensitive to the spectra 
quality. 
Similarity score and dot product have similar mechanism. It treats each spectrum as 
an n-dimension vector, where n is the number of m/z value considered. The score is 
calculated based on the cosine angle of two vectors. Similarity score scales the value 
between 0 to 1 by calculating the ratio between geometric mean and the arithmetic mean 
of corresponding intensities of two spectra (Equation 3.6). 
 
Similarity Score =
(kIs,i Ir ,i )
0.5∑






Equation 3.6  
where Is,i is the peak intensity of the ith m/z value in the sample spectra, Ir,i is the peak 
intensity in the reference spectra (library or training). k is the normalization term that is 
related to the sum of all the peaks intensities the spectra. 
Besides, principle component analysis (PCA) is another most frequently used 
classification tool, which calculates orthogonal transformation to project the spectra data 
into a direction with the largest variance. It is good as a feature filterer by selecting only 
the largest components and also as a preliminary step to view the classification for limited 
groups of samples with relatively data quality. 
Peak-maching Score =







The data analysis is using software Matlab (version R2012b, MathWorks, Natick, MA, 
USA). Prepossessing and power normalization are self-written packages; PCA analysis is 
done by build-in PCA function in Matlab package; similarity score and peak matching are 
self written according to the Equation 3.5 and Equation 3.6. 
SVM training and testing are accomplished by online available packages32. Function 
of picking characteristic peaks analysis, ranking of similarity and plotting figures are self-
written code based on the intermediate variable in SVM model. 
 
3.3! Material and mass spectrometry 
D-aldohexose-glycolaldehydes (GA, Figure 3.1a) of 16 types has been synthesized 
including 8 sugar types and two anomeric configurations (α-D-all, β-D-all, α-D-alt, β-D-
alt, α-D-gal, β-D-gal, α-D-glc, β-D-glc, α-D-glu, β-D-glu, α-D-ido, β-D-ido, α-D-man, β-
D-man, α-D-tal, β-D-tal).  
Disaccharides with 18 types and 6 different non-reducing ends are purchased from 
Sigma-Aldrich, Inc. (St. Louis, MO, USA) or Carbosynth, Ltd. (Berkshire, UK). The 18 
disaccharides are α-D-Galp-(1–3)-D-Gal, α-D-Galp-(1–4)-D-Gal, β-D-Galp-(1–4)-D-Gal , 
β-D-Galp-(1–4)-D-Man, α-D-Galp-(1–6)-D-Glc, α-D-Glcp-(1–2)-D-Glc, β-D-Glcp-(1–2)-
D-Glc, α-D-Glcp-(1–3)-D-fru, α-D-Glcp-(1–3)-D-Glc, β-D-Glcp-(1–3)-D-Glc, α-D-Glcp-
(1–4)-D-Glc, β-D-Glcp-(1–4)-D-Glc, α-D-Glcp-(1–6)-D-Glc, β-D-Glcp-(1–6)-D-Glc, α-
D-Manp-(1–2)-D-Man, α-D-Manp-(1–3)-D-Man, α-D-Manp-(1–4)-D-Man, β-D-Manp-
(1–4)-D-Glc. More information of the use of material and instrumentation can also be 





MS2 CID of deprotonated standards (m/z 221) ion (Figure 3.1b) and MS3 CID of 
diagnostic (m/z 221) ion from disaccharides were collected using ion trap CID on 
4000QTRAPinstrument (Applied Biosystems/ SCIEX, Concord, Ontario, Canada) as 
explained previously.2a In order to avoid space charge effects, the parent ion intensity 
before CID was kept around 1 x 106 counts per second (cps). The remaining parent ion 
intensity after CID was kept around 18 ± 5% relative to its base product ion (100%) to 
obtain reproducible spectra.  
 
3.4! Data groups 
Well-controlled data sets with 16 types (7 mass spectra each) are used as standards 
(reference) for peak matching and similarity score and training groups for SVM. 156 non-
controlled sugar-GAs and 125 disaccharides are used as the testing for all the four 
classification methods. 
For a fair comparison with other classification techniques, all the data has the same 
prepossessing which regulates m/z input from 1 to 350, which is the m/z range of the raw 
data, and the step size as 1. PCA and peak matching has the same normalization method 
which set the maximum to 100. Similarity score uses its own sum-based normalization 
method that has been discussed below. 
 
3.5! Result and discussion 
When the spectra of a sample in a testing group were power-normalized and classified 
using SVM, the sample was assigned to a category based on the ranking of the decision 




to plot an error-PNI curve as part of the error-PNI count plot.  This method was applied for 
classifying 16 types of sugar. 
 
Figure 3.4  Mass spectra of four types of D-aldohexose-glycolaldehydes, including (a) 
alt-α-GA, (b)ido-α-GA, (c) glu-β-GA, and (d)glc-β-GA. Comparing the  four types of 
sugar, they share the same fragment peaks, but with different intensity. 
 
3.5.1! Error-PNI count plot 
The original mass spectra of the carbohydrates share the same dominant peaks with 
slight difference in intensity (Figure 3.4). In the application, the error-PNI plot is drawn in 
Figure 3.5 chosen with PNIs ranges from 0 to 1 (originally calculated from 0 to 2, chosen 










a valley-shaped curve with a minimum value of 0 (zero error in classification) indicating 
the possibility of classifying them from each other based on the mass spectra. 
 
Figure 3.5 Error-PNI plot of 16 types of synthesized monosaccharides-GA. Sugar all-
α is not plotted because no classification error is found along all the PNI. Choosing 
different power index at location ① and ② can result in optimized result for 
classification of glc-β & tal-β and gul-β & ido-α, respectively. 
 
It is obvious that the selection of the PNI value has a significant impact on the accuracy 
in classification. For 14 out of 16 sugars (except for tal-β and ido-α), the assignment is 
improved as the PNI increases and can be achieved with 100% accuracy when PNI is larger 
than 0.5. However, for tal-β and ido-α a 100% accuracy could only be obtained when the 
PNI is lower than 0.5 and 0.34, respectively. This indicates that the dominant fragment 
peaks of the diagnostic ions from these two sugars are not related to the structural 
differences while the peaks of minor intensities are and therefore can be used as biomarkers 






































The error-PNI plot as shown in Figure 3.5 represents a summary of a systematic 
evaluation of the effectiveness of the experimental approach applied for classifying the 
chemical or biological system. The valley in each curve indicates the best normalization 
point for classifying each individual component in the chemical system; the overlap of the 
valleys, if existing, indicates the best normalization point for the global classification of 
the chemical system.   
There is no overlap of optimum index for all the sugars. However, the most 
overlapping valley of most sugars is located near PNI value of 0.5 instead of 1, which is a 
power index applied on the peaks results in no changes to the original value. On the other 
hand, due to the similarity score has an inner scaled factor in the numerator, which is 
equivalent to the effect of a PNI value of 0.5 (Equation 3.6), it has better classification 
accuracy of sugar samples than any other classification methods. However, due to different 
samples may have different optimum power index for analysis, the error-PNI plot can help 
to find the optimum power index and further to enable a multi-step analysis which will be 
discussed later. 
 
Figure 3.6 (a) PCA of 4 types of highly misclassified sugars with PNI 0.5. (b) PCA of the 


































The effect of using an appropriate PNI to classify the data can also be illustrated with 
the impact on the PCA results. Using classification of all-α, alt-β, gal-α and man-β as an 
example, Figure 3.6 shows the PCA results based on the original data and normalized data 
with PNI of 0.5, respectively. Without the normalization, all-α, alt-β, gal-α and man-β 
could not be clearly distinguished (Figure 3.5a); however, after the normalization at PNI 
0.5, the data points for each sample can be much better grouped (Figure 3.5b).  This is 
because an emphasis on the spectral peaks of lower intensities increases the difference 
between the spectra from different types of samples in the classification. This also indicates 
that the peaks of the highest intensities in the mass spectra for these samples might not be 
used as the signature peaks for distinguishing these samples. 
 
3.5.2! Multi-step analysis —an optimization of classification accuracy 
Using the SVM-PNI method involving the CID of the diagnostic ions for classifying 
the sugars mentioned above, normalization at PNI between 0.3 and 0.34 (① in Figure 3.5) 
should be selected to distinguish glc-β and tal-β, but 0.43 to 0.58 should be selected for 
gul-β and ido-α (② in Figure 3.5). Based on the error-PNI plot for the chemical system 
with the 16 sugars, it can be predicted that a complete classification cannot be done with a 
single step using the current analytical method, since there is not an overlap of all the 
valleys of the error-PNI curves. The best overall result for a single step classification would 
be obtained with a PNI between 0.46 and 0.56, where 15 of 16 isomers can be classified 
correctly.  However, based on the error-PNI plot, a multi-step classification can be 
suggested to further improve the classification. For instance, in order to achieve a complete 




15 GAs except for tal-β; at the 2nd step, a PNI =3.2 can be selected to classify tal-β and glc-
β (② in Figure 3.5). 
  
3.5.3! Similarity ranking 
Similarity ranking ranks the decision value of all the data groups based on the testing 
sample (see Section 3.2.1.2). After applying SVM classification with the original spectra 
and the normalized spectra at PNI 0.5, the similarity rankings for ido-α are shown in Figure 
3.7, respectively. The ranking was based on the sum of distance D (Figure 3.2 and Equation 
3.3 )between the testing samples and the classification boundaries (Figure 3.7 inset).  
Without the power normalization, the ido-α sample was wrongfully assigned as glc-β, as 
shown in Figure 3.7a, which can be corrected by normalization with proper PNI (Figure 
3.7b).    
 
Figure 3.7 Similarity ranking based on distance value for testing sample ido-α (a) without 
and (b) with a power normalization at PNI 0f 0.5. Inset in panel (a) and (b) shows the 

















































































































3.5.4! Biomarker identification  
The normal vector ω (in Equation 3.1 and Equation 3.2) of the corresponding PNI in 
the classification can be used to select the characteristic peaks for each sample type. The 
peaks with the highest ω value contribute the most in terms of distinguishing the sample 
from others.  Using the distinction between the glc-α and alt-β samples as an example, the 
top 10 candidate peaks ranked for the decision-making are m/z 99, 159, 131, 129, 161, 83, 
177, 98, 221 and 87 ((Table 3.1).). 7 out of 10 of the characteristic peaks matches to the 
selection which is proposed for all the sugars3. Noticing that the difference in characteristic 
peaks between experienced selection and PNI-SVM is mostly the ranking order, which is 
the weighing factor of peaks in the accurate classification, this may be another reason why 
classification of oligosaccharides is a challenge. 
























87 99 101 113 129 131 159 161 203 221 
PNI-SVM  99 159 131 129 161 83 177 98 221 87 
 
Similarly, comparing the loading plots with and without power normalization of 
sample ido-α and glc-β (Figure 3.8), the data analysis with power normalization identified 
some peaks, such as m/z 71 and 141, which were not previously selected3 as the signature 





Figure 3.8 Loading plot of PNI-SVM to classify the two highly similar sample groups 
ido-α and glc-β (a) without and (b) with power normalization at PNI of 0.5. 
 
3.5.5! Controlled and non-controlled mass spectra—an evaluation of critical 
experimental conditions 
Another capability enabled by the analysis with the error-PNI plots is the evaluation 
of the critical experimental conditions. In previous studies,3,4 it has been claimed that the 
CID conditions, viz. the precursor ion intensity kept at 18 ± 5% relative to the base product 
ion after CID,4 was critical for using the diagnostic ions m/z 221 to identify the correct 
anomeric configurations. To test the need of retaining this condition for the analysis when 
the data analysis with spectral power nomination, we collected additional 132 MS/MS 
spectra (Table 3.2) without carefully tuning the CID condition as described above.  The 
variation of the intensity ratio between the precursor ion and base product ion was in a 
range of 24% - 100%.  The SVM model was still trained using the 136 data sets collected 

























Table 3.2 Quantity of 16 types of sugars in controlled and non-controlled condition. 
            Condition 
   Identity 
Controlled data Non-controlled data Total 
all-α 7 10 17 
all-β 8 9 17 
alt-α 8 9 17 
alt-β 7 10 17 
gal-α 12 4 16 
gal-β 8 10 18 
glc-α 10 6 16 
glc-β 10 6 16 
gul-α 7 10 17 
gul-β 9 8 17 
ido-α 11 6 17 
ido-β 9 7 16 
man-α 7 10 17 
man-β 7 10 17 
tal-α 7 9 16 
tal-β 9 8 17 
Total 136 132 268 
 
Table 3.3 Accuracy of classification of SVM and similarity score. 












SVM 135/136 132/132 65/66 59/59 
 
3.5.6! Comparison of classification algorithms 
Four algorithms PCA, peak ranking, similarity score and SVM are compared (Figure 
3.9). Due to fact that PNI-SVM is the profile-based analysis and has training process to 
filter out irrelevant peaks, it has the best performance in analyzing low quantity samples 
with large data volume with noisy background and matrix effect, which is usually the 





Figure 3.9 (a) PCA score plot of all the 16 types of synthesized standards. Circled area is 
where PCA fails to classify. (b) Rank of peak-matching score of the synthesized standard 
β-D-altp-GA. Result shows that very similar matching scores may appear for similar 
samples. (c) One example, similarity score plot of test data α-D-Glcp-(1-4)-D-Glc. Result 
shows that it is not ideal for noisy data, which characteristics are buried with irrelevant 
peaks. (d) Distance value plot of test sample α-D-Glcp-(1-4)-D-Glc with boundary figure 
of top three ranking types at right top. 
 
In Figure 3.9a, only 3 out of 16 types of sugar can be clearly classified on the two-
direction map of PCA score plot with 112 well-controlled standards of 16 types. Because 
of the mechanism of PCA is to calculate largest variances among each instance, it has high 
possibilities to ignore the important peaks to some degree. Thus, the outliers will largely 
distort the projection map and same problem may also arise if groups classified have both 
very similar groups and distinct groups.  
 For each testing spectra, peak matching ranks the matching score of each standard 
group.  Example shows one ranking histogram of well-controlled standard β-D-altp-GA 






intensity information, the matching score may be too similar to have statistical significance 
to classify the groups. Thus, Extra assistance in matching spectra may be needed, for 
example experienced annotation, which is labor-intensive. 
 
Figure 3.10 (a) Averaged standard data of sugar type β-D-Glc (b) one example of noisy 
data of disaccharides β-D-Glcp-(1-6)-D-Glc which similarity score fails to detect. 
 
Due to inner scalar 0.5 applied (see Section 3.5.1), the similarity score performs as 
well as PNI-SVM, which has classification accuracy approaching 100%. The ranking result 
of one example of disaccharide data α-D-Glc-(1-4)-D-Glc (Figure 3.10) by similarity score 
and SVM has been shown in Figure 3.9c and Figure 3.9d, respectively. In this case, 
similarity score fails in classification, where the correct group is only ranked as the third 
with the highest score lowered than 0.8, which indicate the high noise level of the original 
mass spectra (Figure 3.10). A boundary figure with three top ranking groups is presented 
to show the classification result of PNI-SVM (Figure 3.9d top). Because of the training 








 In the study, power normalization with SVM for classifying oligosaccharides based 
on the sugar type and anomeric configuration of non-reducing end has been proposed. 
Depending on the shape and relative position of the error-PNI curves, the best PNIs can be 
selected to classify samples with lower error due to the intensity of biomarker peaks is 
weighted more to contribute to the classification. Based on the optimum PNI, characteristic 
peaks can be selected and similarity ranking can be performed. Also, a multi-step model 
has been introduced to further increase the classification accuracy by choosing different 
PNIs for classifying different types of sugars. 
By comparison with other classification algorithms for mass spectrometry with noisy 
background and highly similar peaks, the result shows that finding the PNI distribution can 
highly increase the classification efficiency and the method is ideal for guiding biomarker 
identification and sample classification for data with high volume, low data quantity and 
high matrix effect, especially in the early stage study. Though, the model parameter is 
optimized for oligosaccharides, however the general concept and procedures of 
implementation can be used to efficiently guide and evaluate the possibility of biomarker 
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CHAPTER 4.!RELEVANCE ANAYSIS— AN INFORMATICS APPROACH FOR 
SYSTEMATIC EVALUATION AND GUIDANCE OF METHOD 
DEVELOPMENT FOR BIOMATKER IDENTIFICATION IN EARLY-STAGE 
STUDY USING MASS SPECTROMETRY 
4.1! Introduction 
Classification based on mass spectrometry (MS) analysis has been widely practiced in 
biological studies, including proteomics,1-5 disease diagonosis,6-10 bacteria 
identifications,11,12 structure analysis of carbohydrates13,14, and etc. The general approach 
is to extract the characteristic features from the mass spectra to distinguish different types 
of samples.  This can be done as simple as by observing a single peak, but in most of the 
cases a unique set of multiple peaks needs to be used in the data analysis. Those peaks 
represent the existence of a set of chemical or biological compounds of different 
concentrations. The classification based on the set of unique peaks can be done using peak 
correlation or matching3,4,15, which counts the identical peaks between samples and library, 
and statistical methods, such as standard deviation6, t-test8 and ANOVA16, which are 
mostly used in proteomics and metabolomics2,17,18 to determine the identity of a sample.19,20 
The distinction between the samples often could not be simply based on the existence of 
the peaks in the spectra, but also their absolute or relative concentrations, which therefore 
the unique profiles of a set of compounds are used for the sample classification and 
biomarker identification. Pattern recognition methods or machine learning methods have 




 supporting vector machine (SVM)22,23, decision tree24 and neural networks25. Analysis of 
peak profiles extracts the information from the mass spectra in a way very different from 
the peak-by-peak analysis approaches19,20 and can also comprehensively reveal different 
aspects of the samples. 
Classification and biomarker identification by peak profiles are dependent on the 
significance of peaks included in the mass spectra, thereby peaks with high intensities 
weight more in the classification19,26,27. In analysis of complex samples or in early stage 
study, however, characteristic peaks are mostly suppressed by sample matrix and their 
intensities can be of relatively low levels and not stable compared to the matrix effect. It 
lowers the classification accuracy and induces bias when pre-selecting of the mass range 
is performed.   
Power normalization is a systematical and efficient method to evaluate the possibility 
of all the peaks of being biomarkers with less bias on their intensities. It uses Power 
nominalization index (PNI) to rescale the intensities of all the peaks and uses error-PNI 
count plot to find optimized classification result. It serves as a unique but effective tool 
facilitate a comprehensive analysis of the data, which ultimately a reflection of the 
analytical approach adopted for the biological study. 
Based on power normalization, in this study, we explored relevance analysis to further 
assist sample classification. It analyzes the relation between the classification preference 
and the original groups at all PNIs and uses the relation to establish multi-step analysis and 
estimate probability of sample identity. A distinct feature of this method is the relevance 
analysis enables to find out the regular systematic errors in classification and further 




experimental studies6,8,12 previously reported were used for the development and validation 
of this method. 
'
4.2! Method For Data Processing and Analysis 
In order to process mass spectrum efficiently, each mass spectrum is converted into a 
vector, which each dimension is a particular m/z value and the value of the each element 
is the intensity of the peak in the corresponding dimension (m/z). In the study, each 
spectrum is applies with power normalization first, then mass spectra in each category are 
divided into training and testing groups, which training is used to generate classification 
boundary (model) and testing is used to evaluate the model performance (classification 
accuracy). The classification is done by multi-class SVM at each PNI. The SVM method 
has been shown to be powerful in classifications with lower number of samples28, which is 
particularly suitable for early-stage studies with limited number of samples involved. The 
testing results can then be used to construct the error-PNI count maps.  
 
4.2.1! Multi-class SVM and decision scores 
Multi-class SVM analysis of data after the power normalization has been used to 
evaluate the impact by the selection of PNI for the sample classification (see Chapter 3.2.1) 
The decision score was calculated using the sum of distances (D) between the testing 
sample and all the classification boundaries for different sample types.  This works 
particularly well for testing of the initial analysis in an early-stage study, where the number 
of possible sample types is typically larger than the replicates of each sample type The 






where ω is the normal vector of the hyperplane. The larger is the distance, the further is the 
sample away from the classification boundary, which means a higher possibility for correct 
assignment to the corresponding group.  




where n is the total number of the sample types in the classification. The calculated decision 
values D can be used to support a variety of data analysis, such as the similarity ranking of 
all the possible sample types for a sample tested and the ranking of the characteristic peaks 
(biomarkers) which contribute the most to the classification. 
 
4.2.2! Power Normalization 
The power normalization was used to adjust the relative contribution of peaks of 
different intensities in the decision value of classification. It is performed by scaling the 
intensity of all the peaks in the mass spectra with a power normalization index (PNI, 
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where peaki is the original peak intensity of the ith peak in the spectra and Peaki is the scaled 
intensity after the power normalization. The denominator, the square root of the sum of 
squares of all the peak intensities, was used so to achieve an energy balance in every 
spectrum. A PNI lower than 1 decreases the difference in relative intensities, thereby, 
increases the weighing factor of the peaks with lower intensities.  
The data analysis is using software Matlab (version R2012b, MathWorks, Natick, MA, 
USA). The packages available online29 were used to perform SVM. Other functions 
including relevance analysis and error analysis were programed based on the output 
variable in the SVM model.   
 
4.3! Result and Discussion 
Data sets from four previously reported studies were adopted in this study to test and 
validate the method described above, including lipid profiles of eighteen types of 
bacteria,12 and peptides in human blood samples from patients with melanoma6 and breast 
cancer.30 These data sets were all recorded in early-stage studies, where new analytical 
methods were developed for potential distention of the samples of different types. The 
number of samples for each type is relatively low and conditions for experimental control 
might vary significantly. 
 
4.3.1! Multistep analysis by error-PNI plot using Bacteria data 
In a previous study, low temperature plasma was used to perform a direct analysis of 
bacteria12, including bsubtilis, E. coli K12, SAR A19, SAR A1, SAR A20, SAR A2, SAR 




Ber- tani (LB) agar. As for a typical early-stage study, the study included limited sample 
quantity, viz. five spectra for each of 16 bacteria types, and the spectra were subjected to 
high matrix effects. For the testing of the classification, one sample of each bacteria was 
randomly selected as the testing sample and the rest were used for training.  As shown in 
Figure 4a and b, while peaks in the m/z range above 200 attribute to fatty acid ethyl esters 
from the bacteria membrane, there are abundant peaks in the lower m/z range due to the 
sample matrices. Applying the classification method with power normalization, the effect 
of pre-selecting a mass range can be systematically analyzed and a clear strategy for 
classification can be derived.    
Error-PNI plot is a relation between the frequency of classification errors and the PNI 
assigned to normalize the mass spectra. As stated before, if the analyzed mass spectra can 
be used for biomarker identification, the curve in the plot will show a trend with gradually 
lowered valley, where the overlapping valleys for different data groups indicates the best 
PNI used to classify the data groups. This is because the PNIs in the overlapping range 
emphasizes the characteristic peaks to distinguish different data groups, and then, due to 
the difference among mass spectra is enlarged, the data groups can be classified by SVM 
with lower error. Thus, with the help of error-PNI plot, evaluation of biomarker 
identification can be based on the curve shape and relative positions of error-PNI plots; 





Figure 4.1. Mass spectra of (a) SAR A50 and (b) SAR A51. The blue square is the location 
of mass range selection in the previous study. Error-PNI plots (c) without and (d) with mass 
range selection.  
 
The error-PNI plot for classification without pre-selecting the m/z range is shown in 
Figure 4.1c, with the error-PNI curves highlighted for four types, SAR A50, SAR A2, SAR 
A47 and SAR A51, which are highly similar in terms of the lipid profiles in the mass 
spectra12 and could not be well distinguished (Figure 4.1a and b, Figure 4.2a).  Obviously 
there is a difficulty in classifying these samples, with no overlap of the valleys in the error-
PNI curves (Figure 4.1c).  With the m/z range 250-300 pre-selected, the possibility for 
correct classifications is significantly improved (Figure 4.1d).  At PNI at 0.7 (① in Figure 
4.1d), 15 of 16 bacteria can be correctly classified, except for SAR A47, which can be 
correctly classified without power normalization (PNI = 1, at ② in Figure 4.1d).   Based 
on these results, a two-step procedure shall be used for the classification of all the bacteria 










































































using SVM, with the first step based on the original data followed by a 2nd step applying 
power normalization at PNI of 0.7. 
   
Figure 4.2. PCA of 14 types of bacteria data. (a) PCA plot with experienced mass 
range selection to eliminate the matrix effect. (b) PCA plot without mass range selection. 
 
 
4.3.2! Relevance profile in multi-step analysis using Melanoma 
Similar error analysis was performed to classification of different stages of melanoma. 
In the previous study,6 serum samples from B16 mouse model were used to detect the 
pulmonary metastatic melanoma. Samples were collected at four different time points, 
before the injection of the melanoma cells (day 0), and on day 7, 14 and 21 after the 
injection (Figure 4.3). On-chip fraction was used followed by positive mode MALDI-TOF 
analysis of the peptides.  Thirty samples were collected for each stage. For the classification 
in this study, one sample was randomly chosen for the testing and the rest 29 samples were 
used for training in SVM. The PNI range was 0.01 to 2, at a step size of 0.05. 









































































Figure 4.3. Averaged mass spectra of melanoma with developmental stage (a) 0 day 
(b) 7 day (c) 14 day and (d) 21 day. 
 
The error-PNI plot for the data analysis is shown in Figure 4.4a. The samples collected 
on day 7, day 14 and day 21 can be distinguished from each other at a relatively high 
confidence, when using SVM classifications with normalization at PNI between 0.46 and 
0.51; however, the error for classifying the cancer stage at day 0 can be as high as nearly 
30%.  The assignments of the day 0 samples are summarized in Figure 4.4b, with about 
15% misclassified as “day 7” and 15% as “day 14”. The “day 0” and “day 21” samples, 
however, can be distinguished from each other very well at PNI 0.5.  


































Figure 4.4. (a) Error-PNI plot of classification of melanoma samples. (b) 
Classification result of the “0 day” samples. 
 
The misclassification of “day 0” samples can be systematically analyzed over the 
entire PNI range and the result is shown in Figure 4.5.  At a PNI of 0.1, a very few of “0 
day” samples are misclassified as “day 7” or “day 14” but not as “day 14”. At a PNI larger 
than 0.3, “day 0” samples can be completely distinguished from “day 21” samples but not 
from “day 14” or “day 21”. Thus, when selecting certain PNIs, some data group will 
invariably be classified as some other groups. This trend is due to the weighing of some 
peaks in the testing groups happens to fit the characteristics of the other group. Thus, the 
trend of classification errors when sweeping PNIs is the relevance of different sample 





































Figure 4.5. Relevance analysis of the original “0 day” samples. Sample count is the 
total number of samples that classified as the corresponding groups. It describes the 
classification result of the original “0 day” sample at different PNIs. 
 
The plot in Figure 4.5is termed as the “relevance profile” for the “day 0” samples, 
which reveals the relevance between the “day 0” samples and any of the other types of 
samples.  This type of analysis is extremely useful for selecting the strategy and using the 
proper power normalization to distinguish the target sample type (here the “day 0”) from 
any other types at the highest confidence. 
 
4.3.3! Error source profile and probability estimation using Breast Cancer 
In another study, peptides circulating in blood, which were cleaved by 
carboxypeptidase N in the tumor microenvironment, were collected and analyzed in order 
to identify the developmental stages of breast cancer.8 Circulating peptides in 58 human 
plasma samples have been profiled using MALDI-TOF MS, including 10 samples of 
healthy controls (Control), 11 samples with stage I (BC-I), 12 samples with stage II (BC-
II), 15 samples with stage III (BC-III) and 10 samples with stage IV (BC-IV) breast cancer. 
Each sample had two replicates. For testing the SVM with power normalization in this 
























training in SVM. The PNI was selected from 0.01 to 2 with a step size of 0.05. The samples 
were extracted from serum and high matrix effects were observed (Figure 4.6).  The error-
PNI plot (Figure 4.7) indicates a high possibility of error if the original data (PNI = 1) were 
used directly for classification. 
 












Figure 4.7 Error-PNI plot of breast cancer. 
 
As discussed above, a thorough analysis at a system level can be done to understand 
a complicated situation in this case.  In addition to the relevance profile used above, error 
source profile can also be used to summarize the misclassification of other sample types 
into one particular type, as shown in Figure 4.8a for the Control sample type. According to 
the error source profile, no BC-I is misclassified as Control at all PNIs. At PNI around 0.4, 
all the samples classified as Control are true control samples but at PNI 0.8 nearly 10% of 
the classified Control are actually Stage II and 2% are Stag IV. As the PNI changes, the 
classification components change accordingly.  
 
Figure 4.8 (a) Error source profile of Ctrl. It describes the original categories of the 





































































Probability estimation can be provided by combining classification results at different 
PNIs of an unknown sample, based on the relevance and error source profiles. Using a 
simple case for an example, if one sample is classified as BC-IV at PNI 0.4 but classified 
as Control at PNI 0.8, its true identity can be estimated with a probability. The number of 
samples of each type mis-assigned to BC-IV at PNI 0.4 and to Control at PNI 0.8 can be 
extracted from the error source profiles of BC-IV and Control types (Figure 4.8b), as listed 
in Table 1.  The possibility of the said sample to actually be a Control type sample but 
being mis-assigned as the BC-IV can be calculated as pctrl=(32/52)(16/52), where 52 is the 
total number of the sample.   The possibility for being a BC-II samples is pBC-II = 
(2/52)(25/52).  Most likely, this sample would not be BC-I, BC-III or BC-IV based on the 
information listed in the table.  When a sample is determined to be a Control type based on 
the classification using the data analysis reported here, the probabilities of its being a true 
Control type are calculated as Pctrl = pctrl/(pctrl+pBC-II) = 92% .  There is an 8% possibility 
for its being a BC-II type sample. SVM with power normalization at multiple PNI values 
enables a comprehensive analysis of the data that can assist the process of finding the 
ultimate solution in the classification.  The information on the mis-assignments can be used 
for the sample classification as well.   
Table 1. Numbers of samples of each type assigned as BC-
IV at PNI 0.4 and as Control at PNI 0.8 (total 52 samples). 
PNI PNI 0.4 PNI 0.8 
                         Classified as  
Sample Type BC-IV Ctrl 
Ctrl 32 16 
BC-I 25 0 
BC-II 24 2 
BC-III 29 0 





One interesting observation is that even though the unknown sample has not been 
classified as BC-II at either PNI mentioned, there is probability of the sample to be a BC-
II. It is because the classification relation between BC-II and BC-IV at some PNIs. In 
another word, the sample mass spectrum is more similar to BC-IV when it is normalized 
with certain PNI. Obtaining the classification result of more PNIs may improve the 
probability estimation due to more information from relevance file can be used. Taking 26 
data sets of BC-IV for example, choosing PNI from 0.5 to 2 with step size 0.5, the 
probability estimated of being BC-IV are larger than 45% in the 25 out of 26 samples. 
Besides BC-IV, some samples also have higher probability as Ctrl and BC-II. It may due 
to the classification based on histology is not perfectly corresponded to the molecular-level 
change which is detected in the Mass Spectrometry.  
 
4.4! Conclusion 
In the study, relevance analysis including multistep analysis, relevance profile and 
error source profile is proposed to efficiently evaluate sample classification and estimate 
sample identity with low sample quantity, high data volume and high matrix effect 
especially at early stage study. The selection of multiple proper normalization factors 
enables multistep analysis with higher classification accuracy while the analysis of 
relevance profile is performed. Based on relation of classification preference at all PNIs, 
error source profile were introduced to facilitate a comprehensive analysis of the sample 
identity by find the classification probability, which is performed by finding all the 
misclassified or regular error pair.Its applications in data analysis for the studies involving 




multi-dimension data analysis enabled by the power normalization at various PNI values 
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